CJC 1131
Alternative Names: DAC™:GLP-1; DAC™:Glucagon-like peptide-1Latest Information Update: 21 Mar 2007
Price :
$50 *
At a glance
- Originator ConjuChem Biotechnologies
- Class Antihyperglycaemics; Peptides
- Mechanism of Action Glucagon-like peptide 1 stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Type 2 diabetes mellitus
Most Recent Events
- 21 Mar 2007 Discontinued - Phase-II for Type-2 diabetes mellitus in Canada (SC)
- 21 Mar 2007 Discontinued - Phase-II for Type-2 diabetes mellitus in Europe (SC)
- 21 Mar 2007 Discontinued - Phase-II for Type-2 diabetes mellitus in USA (SC)